A carregar...
Emerging strategies for exploiting cannabinoid receptor agonists as medicines
Medicines that activate cannabinoid CB(1) and CB(2) receptor are already in the clinic. These are Cesamet® (nabilone), Marinol® (dronabinol; Δ(9)-tetrahydrocannabinol) and Sativex® (Δ(9)-tetrahydrocannabinol with cannabidiol). The first two of these medicines can be prescribed to reduce chemotherapy...
Na minha lista:
| Autor principal: | |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Blackwell Publishing Ltd
2009
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2697681/ https://ncbi.nlm.nih.gov/pubmed/19226257 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1476-5381.2008.00048.x |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|